Your browser doesn't support javascript.
loading
Relationship Between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients With Diabetes and Mild Heart Failure: Results From the CANDLE Trial.
Nakatani, Daisaku; Dohi, Tomoharu; Hikoso, Shungo; Tanaka, Atsushi; Nanasato, Mamoru; Shimizu, Wataru; Node, Koichi; Sakata, Yasushi.
Afiliação
  • Nakatani D; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Dohi T; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Hikoso S; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tanaka A; Department of Cardiovascular Medicine, Saga University, Saga Japan.
  • Nanasato M; Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan; and.
  • Shimizu W; Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.
  • Node K; Department of Cardiovascular Medicine, Saga University, Saga Japan.
  • Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
J Cardiovasc Pharmacol ; 82(1): 61-68, 2023 07 01.
Article em En | MEDLINE | ID: mdl-37070931
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão